RU93035895A - METHOD FOR TREATING GENERALIZED PERIODONTITIS - Google Patents

METHOD FOR TREATING GENERALIZED PERIODONTITIS

Info

Publication number
RU93035895A
RU93035895A RU93035895/14A RU93035895A RU93035895A RU 93035895 A RU93035895 A RU 93035895A RU 93035895/14 A RU93035895/14 A RU 93035895/14A RU 93035895 A RU93035895 A RU 93035895A RU 93035895 A RU93035895 A RU 93035895A
Authority
RU
Russia
Prior art keywords
cosmol
generalized periodontitis
processes
remission
proposed
Prior art date
Application number
RU93035895/14A
Other languages
Russian (ru)
Other versions
RU2070031C1 (en
Inventor
Г.М. Вишняк
Ю.Г. Григоров
В.В. Поворознюк
И.П. Мазур
Original Assignee
Уральский научно-исследовательский институт геронтологии АМН Украины
Filing date
Publication date
Application filed by Уральский научно-исследовательский институт геронтологии АМН Украины filed Critical Уральский научно-исследовательский институт геронтологии АМН Украины
Priority to RU93035895A priority Critical patent/RU2070031C1/en
Priority claimed from RU93035895A external-priority patent/RU2070031C1/en
Application granted granted Critical
Publication of RU2070031C1 publication Critical patent/RU2070031C1/en
Publication of RU93035895A publication Critical patent/RU93035895A/en

Links

Claims (1)

Изобретение относится к медицине, а именно к терапевтической стоматологии. Целью изобретения является разработка способа патогенетического лечения генерализованного пародонтита (ГП), удлинение сроков ремиссии. Предлагается применять биологически активный продукт питания "Космол", который способствует нормализации метаболических процессов. Космол назначают внутрь по 20 г 2 раза в день после еды в течение 60 дней. Предложенный способ патогенетического лечения ГП с использованием "Космола" обладает высоким терапевтическим эффектом, удлиняет сроки ремиссии, что позволяет рекомендовать его для профилактики развития патологических процессов в тканях пародонта и коррекции развившихся дистрофически-воспалительных процессов при генерализованном пародонтите.The invention relates to medicine, namely to therapeutic dentistry. The aim of the invention is to develop a method for the pathogenetic treatment of generalized periodontitis (GP), lengthening the duration of remission. It is proposed to use the biologically active food product "Cosmol", which helps to normalize metabolic processes. Cosmol is prescribed orally at 20 g 2 times a day after meals for 60 days. The proposed method for the pathogenetic treatment of GP using Cosmol has a high therapeutic effect, lengthens the remission period, which allows us to recommend it for the prevention of the development of pathological processes in periodontal tissues and correction of the developed dystrophic-inflammatory processes in generalized periodontitis.
RU93035895A 1993-07-12 1993-07-12 Method for treatment of generalization parodontitis RU2070031C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93035895A RU2070031C1 (en) 1993-07-12 1993-07-12 Method for treatment of generalization parodontitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93035895A RU2070031C1 (en) 1993-07-12 1993-07-12 Method for treatment of generalization parodontitis

Publications (2)

Publication Number Publication Date
RU2070031C1 RU2070031C1 (en) 1996-12-10
RU93035895A true RU93035895A (en) 1997-01-27

Family

ID=20144943

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93035895A RU2070031C1 (en) 1993-07-12 1993-07-12 Method for treatment of generalization parodontitis

Country Status (1)

Country Link
RU (1) RU2070031C1 (en)

Similar Documents

Publication Publication Date Title
RU92004521A (en) APPLICATION OF BISPHOSPHONATES AND EXTRACT OF PARASITIC Glands FOR THE TREATMENT OF OSTEOPOROSIS AND A KIT FOR TREATMENT
DE3856566D1 (en) Treatment of autoimmune diseases by oral administration of autoantigens
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
ATE319474T1 (en) TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS
DE3684190D1 (en) USE OF TETRAHYDROBIOPTERINES FOR PRODUCING A MEDICINE FOR TREATING CHILDREN'S AUTISM.
ES2180646T3 (en) ORAL LIQUID FORMULATIONS OF ALENDRONATE.
EP0830138A4 (en) Use of fibroblast growth factors to stimulate bone growth
CA2116559A1 (en) Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
ATE175348T1 (en) L - DEPRENYL FOR THE TREATMENT OF MACULAR DEGENERATION
CA2184916A1 (en) Use of fibroblast growth factors to stimulate bone growth
FR2721516B1 (en) New uses of a complex based on brain phospholipids in therapy and in food.
ATE99172T1 (en) USE OF ACETYL-L-CARNITINE IN TREATMENT OF CATARACT, AND PHARMACEUTICAL COMPOSITIONS FOR SUCH TREATMENT.
ATE133859T1 (en) SUSTAINED-RELEASE PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PERIODONTAL DISEASES
ATE184788T1 (en) COMPOSITIONS CONTAINING IDEBENONE FOR THE TREATMENT OF ALZHEIMER'S M
JPS57126420A (en) Drug for digestive organ
RU93035895A (en) METHOD FOR TREATING GENERALIZED PERIODONTITIS
DE69315162D1 (en) Use of L-carnitine and acyl-L-carnitine for the treatment of patients suffering from AIDS-related syndromes and of asymptomatic HIV-seropositive patients
Löe et al. 3. The natural history of periodontal disease in man.
NO960347D0 (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
RU2053755C1 (en) Method for treatment of hyperesthesia of tooth solid tissues
SU1119693A1 (en) Method of treatment of initial dental caries
RU2026068C1 (en) Method of psoriasis treatment
RU95102604A (en) Method for treating intestinal dysbacteriosis
ATE82016T1 (en) 1,4-DIHYDROPYRIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
RU95105563A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GASTROENTEROLOGICAL DISEASES AND METHOD OF TREATMENT OF THESE DISEASES